Literature DB >> 22094821

Combinatorial insulin secretion dynamics of recombinant hepatic and enteroendocrine cells.

Kiranmai Durvasula1, Peter M Thulé, Athanassios Sambanis.   

Abstract

One of the most promising cell-based therapies for combating insulin-dependent diabetes entails the use of genetically engineered non-β cells that secrete insulin in response to physiologic stimuli. A normal pancreatic β cell secretes insulin in a biphasic manner in response to glucose. The first phase is characterized by a transient stimulation of insulin to rapidly lower the blood glucose levels, which is followed by a second phase of insulin secretion to sustain the lowered blood glucose levels over a longer period of time. Previous studies have demonstrated hepatic and enteroendocrine cells to be appropriate hosts for recombinant insulin expression. Due to different insulin secretion kinetics from these cells, we hypothesized that a combination of the two cell types would mimic the biphasic insulin secretion of normal β cells with higher fidelity than either cell type alone. In this study, insulin secretion experiments were conducted with two hepatic cell lines (HepG2 and H4IIE) transduced with 1 of 3 adenoviruses expressing the insulin transgene and with a stably transfected recombinant intestinal cell line (GLUTag-INS). Insulin secretion was stimulated by exposing the cells to glucose only (hepatic cells), meat hydrolysate only (GLUTag-INS), or to a cocktail of the two secretagogues. It was found experimentally that the recombinant hepatic cells secreted insulin in a more sustained manner, whereas the recombinant intestinal cell line exhibited rapid insulin secretion kinetics upon stimulation. The insulin secretion profiles were computationally combined at different cell ratios to arrive at the combinatorial kinetics. Results indicate that combinations of these two cell types allow for tuning the first and second phase of insulin secretion better than either cell type alone. This work provides the basic framework in understanding the secretion kinetics of the combined system and advances it towards preclinical studies.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22094821      PMCID: PMC3288548          DOI: 10.1002/bit.24373

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  47 in total

1.  In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoter-enhancer of human cytomegalovirus.

Authors:  N K Grzimek; J Podlech; H P Steffens; R Holtappels; S Schmalz; M J Reddehase
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets.

Authors:  N Lumelsky; O Blondel; P Laeng; I Velasco; R Ravin; R McKay
Journal:  Science       Date:  2001-04-26       Impact factor: 47.728

3.  Induction of human umbilical cord blood-derived stem cells with embryonic stem cell phenotypes into insulin producing islet-like structure.

Authors:  Bo Sun; Kyung-Hwan Roh; Sae-Rom Lee; Yong-Soon Lee; Kyung-Sun Kang
Journal:  Biochem Biophys Res Commun       Date:  2007-01-24       Impact factor: 3.575

4.  Development of a bioartificial pancreas: II. Effects of oxygen on long-term entrapped betaTC3 cell cultures.

Authors:  K K Papas; R C Long; A Sambanis; I Constantinidis
Journal:  Biotechnol Bioeng       Date:  1999       Impact factor: 4.530

Review 5.  Islet cell transplantation.

Authors:  Federico Bertuzzi; Simona Marzorati; Antonio Secchi
Journal:  Curr Mol Med       Date:  2006-06       Impact factor: 2.222

6.  In vitro cultivation of human islets from expanded ductal tissue.

Authors:  S Bonner-Weir; M Taneja; G C Weir; K Tatarkiewicz; K H Song; A Sharma; J J O'Neil
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

7.  Glucose regulated production of human insulin in rat hepatocytes.

Authors:  P M Thulé; J Liu; L S Phillips
Journal:  Gene Ther       Date:  2000-02       Impact factor: 5.250

8.  Engineered enteroendocrine cells secrete insulin in response to glucose and reverse hyperglycemia in diabetic mice.

Authors:  Jaeseok Han; Hyune-Hwan Lee; Hyokjoon Kwon; Seungjin Shin; Ji-Won Yoon; Hee-Sook Jun
Journal:  Mol Ther       Date:  2007-02-13       Impact factor: 11.454

9.  Murine cytomegalovirus major immediate-early enhancer region operating as a genetic switch in bidirectional gene pair transcription.

Authors:  Christian O Simon; Birgit Kühnapfel; Matthias J Reddehase; Natascha K A Grzimek
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

10.  In vivo reprogramming of adult pancreatic exocrine cells to beta-cells.

Authors:  Qiao Zhou; Juliana Brown; Andrew Kanarek; Jayaraj Rajagopal; Douglas A Melton
Journal:  Nature       Date:  2008-08-27       Impact factor: 49.962

View more
  2 in total

1.  Therapeutic effects of a non-β cell bioartificial pancreas in diabetic mice.

Authors:  Aubrey R Tiernan; Peter M Thulé; Athanassios Sambanis
Journal:  Transplantation       Date:  2014-09-15       Impact factor: 4.939

2.  Trichostatin A affects the secretion pathways of beta and intestinal endocrine cells.

Authors:  Aubrey R Tiernan; Julie A Champion; Athanassios Sambanis
Journal:  Exp Cell Res       Date:  2014-10-16       Impact factor: 3.905

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.